Schedule 13G ownership disclosure

FORTRESS BIOTECH INC

Security class unavailable · CUSIP: 34960Q307

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,734,854
Percent of class
9.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-005995
Form type
SC 13G
Filer
Fortress Biotech, Inc.
CIK
CIK 1429260
Filed
Oct 25, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub